Cargando…
Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients
BACKGROUND: Dioxins and dioxin-like compounds have half-lives typically between 7.2 years and 15 years. Our previous study of patients poisoned by extremely high concentrations of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) in the ‘Yusho incident’ in 1968 found that in some the half-life of blood 2,3,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574225/ https://www.ncbi.nlm.nih.gov/pubmed/26384313 http://dx.doi.org/10.1186/s12940-015-0059-y |
_version_ | 1782390596953964544 |
---|---|
author | Matsumoto, Shinya Akahane, Manabu Kanagawa, Yoshiyuki Kajiwara, Jumboku Mitoma, Chikage Uchi, Hiroshi Furue, Masutaka Imamura, Tomoaki |
author_facet | Matsumoto, Shinya Akahane, Manabu Kanagawa, Yoshiyuki Kajiwara, Jumboku Mitoma, Chikage Uchi, Hiroshi Furue, Masutaka Imamura, Tomoaki |
author_sort | Matsumoto, Shinya |
collection | PubMed |
description | BACKGROUND: Dioxins and dioxin-like compounds have half-lives typically between 7.2 years and 15 years. Our previous study of patients poisoned by extremely high concentrations of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) in the ‘Yusho incident’ in 1968 found that in some the half-life of blood 2,3,4,7,8-PeCDF tended towards infinity. This suggests that there are two groups of Yusho patients, those with 2,3,4,7,8-PeCDF half-lives around 10 years, and those with half-lives near infinity. We sought to establish the proportions of each in a cohort of 395 Yusho patients, and whether the proportions were changing over time. METHODS: We undertook longitudinal measurement of the blood concentration of 2,3,4,7,8-PeCDF in our cohort between 2002 and 2010. We estimated the change in concentration for each patient using linear regression for measured 2,3,4,7,8-PeCDF concentration, then compared the distribution of changes in concentrations with our previous study. RESULTS: In patients in whom the blood concentration of 2,3,4,7,8-PeCDF exceeded 50 pg/g lipid, the proportion 8.0 % of patients exhibiting half-lives less than 13.3 years fell compared with our previous study (28.2 %), while the proportion with near infinity half-lives increased. CONCLUSION: The prolongation of the half-lives was likely a consequence of age-related factors. |
format | Online Article Text |
id | pubmed-4574225 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45742252015-09-19 Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients Matsumoto, Shinya Akahane, Manabu Kanagawa, Yoshiyuki Kajiwara, Jumboku Mitoma, Chikage Uchi, Hiroshi Furue, Masutaka Imamura, Tomoaki Environ Health Research BACKGROUND: Dioxins and dioxin-like compounds have half-lives typically between 7.2 years and 15 years. Our previous study of patients poisoned by extremely high concentrations of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) in the ‘Yusho incident’ in 1968 found that in some the half-life of blood 2,3,4,7,8-PeCDF tended towards infinity. This suggests that there are two groups of Yusho patients, those with 2,3,4,7,8-PeCDF half-lives around 10 years, and those with half-lives near infinity. We sought to establish the proportions of each in a cohort of 395 Yusho patients, and whether the proportions were changing over time. METHODS: We undertook longitudinal measurement of the blood concentration of 2,3,4,7,8-PeCDF in our cohort between 2002 and 2010. We estimated the change in concentration for each patient using linear regression for measured 2,3,4,7,8-PeCDF concentration, then compared the distribution of changes in concentrations with our previous study. RESULTS: In patients in whom the blood concentration of 2,3,4,7,8-PeCDF exceeded 50 pg/g lipid, the proportion 8.0 % of patients exhibiting half-lives less than 13.3 years fell compared with our previous study (28.2 %), while the proportion with near infinity half-lives increased. CONCLUSION: The prolongation of the half-lives was likely a consequence of age-related factors. BioMed Central 2015-09-17 /pmc/articles/PMC4574225/ /pubmed/26384313 http://dx.doi.org/10.1186/s12940-015-0059-y Text en © Matsumoto et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Matsumoto, Shinya Akahane, Manabu Kanagawa, Yoshiyuki Kajiwara, Jumboku Mitoma, Chikage Uchi, Hiroshi Furue, Masutaka Imamura, Tomoaki Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients |
title | Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients |
title_full | Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients |
title_fullStr | Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients |
title_full_unstemmed | Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients |
title_short | Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients |
title_sort | unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (pecdf) levels in yusho patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574225/ https://www.ncbi.nlm.nih.gov/pubmed/26384313 http://dx.doi.org/10.1186/s12940-015-0059-y |
work_keys_str_mv | AT matsumotoshinya unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients AT akahanemanabu unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients AT kanagawayoshiyuki unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients AT kajiwarajumboku unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients AT mitomachikage unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients AT uchihiroshi unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients AT furuemasutaka unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients AT imamuratomoaki unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients |